clinical trials

Novartis suspends platform trial, advancement shot of four blood cancer assets drop
Clinical Trials Arena
Wed, 07/13/22 - 10:07 am
Novartis
clinical trials
blood cancer
tuberculosis
uterine leiomyoma
No news is bad news for Atara
EP Vantage
Wed, 07/13/22 - 09:58 am
Atara Biotherapeutics
ATA188
clinical trials
EBV
Aldeyra says eye drop clears three dry eye signals en route to FDA
Endpoints
Tue, 07/12/22 - 10:51 am
Aldeyra Therapeutics
dry eye disease
FDA
clinical trials
reproxalap
Ionis hands off an antisense drug for kidney disease, giving all rights to Roche
Endpoints
Mon, 07/11/22 - 06:23 pm
Ionis Pharmaceuticals
Roche
IONIS-FB-LRx
clinical trials
immunoglobin A nephropathy
kidney disease
With new data, Pliant drug shows promise in tough-to-treat lung disease
BioPharma Dive
Mon, 07/11/22 - 10:28 am
Pliant Therapeutics
idiopathic pulmonary fibrosis
IPF
PLN-74809
clinical trials
MacroGenics closes solid tumor clinical trial after 7 people die
Fierce Biotech
Mon, 07/11/22 - 10:22 am
clinical trials
Macrogenics
enoblituzumab
solid tumors
patient deaths
AbbVie dumps Alector's Alzheimer's immunotherapy after phase 1 review
Fierce Biotech
Fri, 07/8/22 - 10:43 am
Alector
AbbVie
Alzheimer's disease
clinical trials
AL003
Legend scraps early-stage CAR-T for lymphoma 6 weeks after clinical hold lifted
Fierce Biotech
Fri, 07/8/22 - 10:32 am
Legend Biotech
CAR-T
cell therapy
clinical trials
lymphoma
LB1901
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
BioSpace
Thu, 07/7/22 - 10:41 am
Alvotech
AVT06
biosimilars
clinical trials
Eylea
Nordic Nanovector pulls the plug on troubled Paradigm trial, moves for restructuring
Fierce Biotech
Thu, 07/7/22 - 10:32 am
Nordic Nanovector
clinical trials
Betalutin
refractory follicular lymphoma
CytomX halts lead program and will seek a partner as breast cancer drug disappoints
Endpoints
Thu, 07/7/22 - 10:26 am
clinical trials
CytomX
breast cancer
praluzatamab ravtansine
Veru, Immunome Tout Positive Data for COVID-19 Therapeutics
BioSpace
Wed, 07/6/22 - 11:46 pm
Veru
Immunome
COVID-19
clinical trials
Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder
BioSpace
Wed, 07/6/22 - 10:48 am
Clairvoyant Therapeutics
clinical trials
psilocybin
alcohol-use disorder
Seagen reports positive Phase II tucatinib data in colorectal cancer
Clinical Trials Arena
Tue, 07/5/22 - 11:54 am
Seagen
Tukysa
metastatic colorectal cancer
clinical trials
Endo's frozen shoulder plan comes unstuck, with phase 2 flop driving strategy reevaluation
Fierce Pharma
Tue, 07/5/22 - 10:54 am
Endo International
frozen shoulder
Xiaflex
clinical trials
Another Duchenne clinical hold gets lifted, this time at Dyne Therapeutics
Endpoints
Tue, 07/5/22 - 10:45 am
Duchenne Muscular Dystrophy
clinical trials
Dyne Therapeutics
DYNE-251
Lexicon CEO touts ‘wonderful morning’ as diabetic pain drug clears phase 2, teeing up hopeful partnership talks
Fierce Biotech
Thu, 06/30/22 - 11:03 am
Lexicon Pharmaceuticals
diabetic neuropathy
diabetes
diabetic pain
clinical trials
LX9211
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
BioPharma Dive
Thu, 06/30/22 - 11:01 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
FDA Partially Halts Sanofi’s BTK Inhibitor for Multiple Sclerosis, Myasthenia Gravis
Pharma Live
Thu, 06/30/22 - 10:59 am
Sanofi
multiple sclerosis
myasthenia gravis
FDA
tolebrutinib
clinical trials
clinical hold
Why Global Blood Therapeutics Trended Upward Today
Motley Fool
Wed, 06/29/22 - 05:32 pm
Global Blood Therapeutics
clinical trials
GBT601
sickle cell disease

Pages